Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-60
SponsorArmauer Hansen Research Institute, Ethiopia

About this trial

This study will look at how feasible it is to use thermotherapy (TT) as a treatment for skin(cutaneous) leishmaniasis (CL) in health centers in the Sodo and South Sodo districts, Ethiopia. The main questions the investigators want to answer are:

* Is it practical, acceptable, and suitable to use thermotherapy for treating skin leishmaniasis in these health centers? * How effective is thermotherapy in treating skin leishmaniasis in this setting?

Health centers that do not offer thermotherapy will be used as a comparison group. Patients with CL in these areas will be monitored for up to 3 months before being sent to centers that provide thermotherapy.

Participants will be checked at a nearby health center to see if they meet the criteria for the study and then will be recruited. Patients with skin lesions will receive thermotherapy using the ThermoMed device, which heats the area to 50°C for 30 seconds. Their progress will be checked every 4 weeks until day 90. Depending on how well they respond, thermotherapy may be repeated at 4 or 8 weeks.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Males and females aged ≥12 and ≤60 years old.

Lesion size < or = 4 cm (longest diameter).

Not located adjacent to ear, nose, eyes, lips, or close to mucosal membranes.

Patient with < or = 4 CL lesions

Disqualifiers

Any condition that prevents the patient from following the study treatment and/or the follow-up

Trial design

Design model

Single group

Treatments tested in this trial

  • Thermotherapy

    Device

    Radio frequency-induced heat treatment using the ThermoMed device at 50-degree centigrade for 30 seconds.

Treatment groups

103 Participants
are divided into 1 treatment group
Group A: ThermotherapyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility, acceptability, and appropriateness of integrating TT into primary healthcare.

\- Focus Group Discussion (FGD) and in-depth interview

Time frame
Day 90 reached for 20 patients
2

Feasibility, acceptability, and appropriateness of integrating TT into primary healthcare.

Assessment of Feasibility of Intervention Measure (FIM), Acceptability of Intervention Measure (AIM), and Intervention Appropriateness Measure (IAM) using a validated psychometric tool.

Time frame
Day 90 reached for 20 patients

Secondary outcomes

1

Treatment success rate

The proportion of patients who are cured at day 90. Cure is defined as complete epithelialization for ulcer lesions and complete flattening of nodules.

Time frame
Day 90 reached for all patients
2

Diagnostic accuracy of primary health care staff

Calculating sensitivity, specificity, positive, and negative predictive values of CL diagnosis by primary healthcare staff using PCR as a gold standard.

Time frame
Day 0 for all the participants reached

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.